Soumitra Ghosh

Provide consulting services to pharmaceutical and biotechnology companies for metabolic and inflammatory disease indications in the areas of drug discovery and development, devices, drug delivery, R&D strategy, life cycle planning and intellectual property.

Leader, Research Programs and Collaborations: Directed Amylin’s Research Team, and was responsible for day-to-day operations. Led research programs in peptide and protein-biologics-based drug discovery for metabolic disorders, mass spectrometry-based approaches for peptide hormone discovery, and research evaluation of external opportunities. Provided research support for Byetta®, Symlin®, Bydureon® and Myalept™ development programs and product commercialization. Member of Amylin's intellectual property strategy committee, and provided oversight for external R&D collaborations.

Led a multi-disciplinary group of scientists for: • small molecule drug discovery for osteoarthritis, obesity and neurodegenerative diseases • mitochondrial DNA haplotyping and genetic analysis for disease association studies. • development of proteomics technologies for mapping the mitochondrial proteome and new drug target identification